About
Bispecific Antibody
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
900
By Phase
PHASE2: 1PHASE3: 1PHASE1: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06577935Lead Sponsor
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
PHASE2Recruiting
350 participants
Started: Oct 31, 2024 · Completed: Aug 31, 2027
NCT06115512Lead Sponsor
A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion
PHASE3Recruiting
400 participants
Started: Dec 8, 2023 · Completed: Oct 31, 2025
NCT05225857Lead Sponsor
A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women
PHASE1Completed
90 participants
Started: Jun 28, 2022 · Completed: Jan 13, 2024
NCT05574543Lead Sponsor
A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
PHASE1/PHASE2Completed
60 participants
Started: Dec 1, 2020 · Completed: Jul 13, 2022
Locations (1)
Headquarters
Woodland Hills, CA, United States
Map
Loading map...